Triple
T22651383
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Regulation (EC) No 1394/2007 |
E559101
|
entity |
| Predicate | complements |
P162
|
FINISHED |
| Object | Directive 2001/83/EC on the Community code relating to medicinal products for human use |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Directive 2001/83/EC on the Community code relating to medicinal products for human use | Statement: [Regulation (EC) No 1394/2007, complements, Directive 2001/83/EC on the Community code relating to medicinal products for human use]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2001/83/EC on the Community code relating to medicinal products for human use Context triple: [Regulation (EC) No 1394/2007, complements, Directive 2001/83/EC on the Community code relating to medicinal products for human use]
-
A.
Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products
Directive 2001/82/EC is a key piece of European Union legislation that harmonizes the rules for the authorization, manufacture, distribution, and pharmacovigilance of veterinary medicinal products across EU member states.
-
B.
Regulation (EC) No 141/2000 on orphan medicinal products
Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
-
C.
Community code for medicinal products for human use
chosen
The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
-
D.
Council Directive 93/42/EEC on medical devices
Council Directive 93/42/EEC on medical devices was a key European Union legislative framework that set essential safety and performance requirements for medical devices marketed within the EU.
-
E.
Directive 98/79/EC on in vitro diagnostic medical devices
Directive 98/79/EC on in vitro diagnostic medical devices was an EU legal framework that set safety, performance, and conformity requirements for in vitro diagnostic medical devices placed on the European market.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e245489dd88190b1f674acf61c8769 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1703c5538819089d9b5349f26ea6d |
completed | April 29, 2026, 2:43 a.m. |
Created at: April 17, 2026, 3:06 p.m.